{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:18Z","timestamp":1790009538290,"version":"4.0.1"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biologicals.2024.101784","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T23:47:29Z","timestamp":1721778449000},"page":"101784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2194-5536","authenticated-orcid":false,"given":"Shital S.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-0563","authenticated-orcid":false,"given":"Vikas K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4211-7613","authenticated-orcid":false,"given":"Rajesh Kumar","family":"Kante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7006-2497","authenticated-orcid":false,"given":"Swapan Kumar","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-7356","authenticated-orcid":false,"given":"Rajendra H.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2024.101784_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pathogens12010116","article-title":"Bacterial antibiotic resistance: the most critical pathogens","volume":"12","author":"Biondo","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.biologicals.2024.101784_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.biologicals.2024.101784_bib3","doi-asserted-by":"crossref","first-page":"a010215","DOI":"10.1101\/cshperspect.a010215","article-title":"The pneumococcus: epidemiology, microbiology, and pathogenesis","volume":"3","author":"Henriques-Normark","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.biologicals.2024.101784_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13077","article-title":"Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: from nasopharyngeal colonizer to intracellular pathogen","volume":"21","author":"Subramanian","year":"2019","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2024.101784_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5863\/1551-6776-21.1.27","article-title":"A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.biologicals.2024.101784_bib8","series-title":"Carbohydrate-based vaccines: from concept to clinic","first-page":"323","article-title":"Lessons learned and future challenges in the design and manufacture of glycoconjugate vaccines","author":"Hennessey","year":"2018"},{"key":"10.1016\/j.biologicals.2024.101784_bib9","series-title":"Method for high level production of CRM197","author":"Masilamani","year":"2021"},{"key":"10.1016\/j.biologicals.2024.101784_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fbioe.2020.00039","article-title":"Quality improvement of capsular polysaccharide in Streptococcus pneumoniae by purification process optimization","volume":"8","author":"Lee","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.biologicals.2024.101784_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","article-title":"Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation","volume":"33","author":"Pecetta","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib12","series-title":"ICH Q8: pharmaceutical development","first-page":"1","author":"Berridge","year":"2004"},{"key":"10.1016\/j.biologicals.2024.101784_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J"},{"key":"10.1016\/j.biologicals.2024.101784_bib14","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/JCM.39.9.3373-3375.2001","article-title":"Identification of Streptococcus pneumoniae revisited","volume":"39","author":"Kellogg","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mimet.2017.07.015","article-title":"Current challenges in the accurate identification of Streptococcus pneumoniae and its serogroups\/serotypes in the vaccine era","volume":"141","author":"Varghese","year":"2017","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.biologicals.2024.101784_bib16","first-page":"31","article-title":"Proposal for a change in the nomenclature of Diplococcus pneumoniae and a comparison of the Danish and American type designations","volume":"10","author":"Kauffmann","year":"1960","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib17","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/jcm.26.9.1708-1713.1988","article-title":"Simple genetic method to identify viridans group streptococci by colorimetric dot hybridization and fluorometric hybridization in microdilution wells","volume":"26","author":"Ezaki","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1086\/322803","article-title":"Optochin resistance in Streptococcus pneumoniae: mechanism, significance, and clinical implications","volume":"184","author":"Pikis","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/IAI.68.3.1374-1382.2000","article-title":"Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of \u201catypical\u201d pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes","volume":"68","author":"Whatmore","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2024.101784_bib20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1099\/jmm.0.001022","article-title":"Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains","volume":"68","author":"Gonzales-Siles","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4014\/jmb.0903.3027","article-title":"Optimization of capsular polysaccharide production by Streptococcus pneumoniae type 3","volume":"19","author":"Jin","year":"2009","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2024.101784_bib22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2672.2006.03012.x","article-title":"Introduction of air in the anaerobic culture of Streptococcus pneumoniae serotype 23F induces the release of capsular polysaccharide from bacterial surface into the cultivation medium","volume":"101","author":"Goncalves","year":"2006","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib23","series-title":"A novel process of cultivating bacteria for yield improvement of capsular polyoses","author":"Kapre","year":"2013"},{"key":"10.1016\/j.biologicals.2024.101784_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119783","article-title":"Purification of capsular polysaccharides isolated from S. pneumoniae serotype 2 by hydrogen peroxide and endonuclease","volume":"294","author":"Gaikwad","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.biologicals.2024.101784_bib25","series-title":"Methods for simultaneous fragmentation and purification of bacterial polysaccharides","author":"Dhere","year":"2023"},{"key":"10.1016\/j.biologicals.2024.101784_bib26","series-title":"Removal of Polyose type teichoic acid contaminants from bacterial polyoses","author":"Kapre","year":"2012"},{"key":"10.1016\/j.biologicals.2024.101784_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AEM.67.2.969-971.2001","article-title":"Production of capsular polysaccharide of Streptococcus pneumoniae type 14 and its purification by affinity chromatography","volume":"67","author":"Su\u00e1rez","year":"2001","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4014\/jmb.1010.10043","article-title":"Purification of capsular polysaccharide produced by Streptococcus pneumoniae serotype 19A","volume":"21","author":"Jung","year":"2011","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2024.101784_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/0104-6632.20160333s20150140","article-title":"Development of a new process for purification of capsular polysaccharide from Streptococcus pneumoniae serotype 14","volume":"33","author":"Zanardo","year":"2016","journal-title":"Braz J Chem Eng"},{"key":"10.1016\/j.biologicals.2024.101784_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4014\/jmb.1010.10043","article-title":"Purification of capsular polysaccharide produced by Streptococcus pneumoniae serotype 19A","volume":"21","author":"Jung","year":"2011","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.biologicals.2024.101784_bib31","first-page":"664","article-title":"Purification of Streptococcus pneumoniae capsular polysaccharides using aluminium phosphate and ethanol","volume":"6","author":"Macha","year":"2014","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"10.1016\/j.biologicals.2024.101784_bib32","series-title":"Purification of capsular polysaccharides","author":"Kapre","year":"2011"},{"key":"10.1016\/j.biologicals.2024.101784_bib33","series-title":"Method of obtaining purified bacterial polysaccharides","author":"Dhere","year":"2021"},{"key":"10.1016\/j.biologicals.2024.101784_bib34","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2024.101784_bib35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib36","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2024.101784_bib37","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2024.101784_bib38","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.biologicals.2024.101784_bib39","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.vaccine.2010.04.072","article-title":"Overview of the development and current use of CRM197 conjugate vaccines for pediatric use","volume":"28","author":"Shinefield","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201700168","article-title":"High\u2010yield production of recombinant CRM197, a non\u2010toxic mutant of diphtheria toxin, in the periplasm of Escherichia coli","volume":"12","author":"Goffin","year":"2017","journal-title":"Biotechnol J"},{"key":"10.1016\/j.biologicals.2024.101784_bib41","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/S0021-9258(19)43810-6","article-title":"Diphtheria toxin and related proteins: I. Isolation and properties of mutant proteins serologically related to diphtheria toxin","volume":"248","author":"Uchida","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12257-016-0360-9","article-title":"Optimization of diphtheria toxin production by Corynebacterium diphtheriae using a casein-based medium in a fermenter","volume":"21","author":"Chung","year":"2016","journal-title":"Biotechnol Bioproc Eng"},{"key":"10.1016\/j.biologicals.2024.101784_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.biologicals.2016.08.002","article-title":"Process optimization for an industrial-scale production of Diphtheria toxin by Corynebacterium diphtheriae PW8","volume":"44","author":"Suwanpatcharakul","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2024.101784_bib44","first-page":"404","article-title":"The manufacture and quality control of immunological products","volume":"23","author":"Sandle","year":"2023","journal-title":"Hugo Russell\u2019s Pharmaceut Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/toxins15090563","article-title":"Recent developments in vaccine design: from live vaccines to recombinant toxin vaccines","volume":"15","author":"Gupta","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.biologicals.2024.101784_bib46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib47","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1016\/j.vaccine.2022.07.011","article-title":"Genetically detoxified tetanus toxin as a vaccine and conjugate carrier protein","volume":"40","author":"Chang","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/21645515.2015.1086048","article-title":"Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates","volume":"12","author":"Br\u00f6ker","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2024.101784_bib49","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.4161\/hv.26109","article-title":"Protein carriers of conjugate vaccines: characteristics, development, and clinical trials","volume":"9","author":"Pichichero","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2024.101784_bib50","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/S0264-410X(00)00082-7","article-title":"Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide\u2013N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys","volume":"18","author":"McNeely","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/mpat.1994.1068","article-title":"Insertional inactivation of the gene for the meningococcal lactoferrin binding protein","volume":"17","author":"Quinn","year":"1994","journal-title":"Microb Pathog"},{"key":"10.1016\/j.biologicals.2024.101784_bib52","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib53","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/2211-5463.13498","article-title":"Haemophilus influenzae Protein D antibody suppression in a multi\u2010component vaccine formulation","volume":"12","author":"Michel","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.biologicals.2024.101784_bib54","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150269","article-title":"Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis","volume":"6","author":"Hathaway","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.biologicals.2024.101784_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2022.108503","article-title":"Partial depolymerization of capsular polysaccharides isolated from Streptococcus pneumoniae serotype 2 by various methods","volume":"512","author":"Gaikwad","year":"2022","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biologicals.2024.101784_bib56","series-title":"Methodology for structural analysis of polysaccharides","first-page":"37","article-title":"Partial acid hydrolysis and molecular degradation","author":"Guo","year":"2018"},{"key":"10.1016\/j.biologicals.2024.101784_bib57","series-title":"Acid hydrolysis of polysaccharide-containing raw material","author":"Kiminki","year":"1977"},{"key":"10.1016\/j.biologicals.2024.101784_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.121204","article-title":"Effect of trifluoroacetic acid on the antigenicity of capsular polysaccharides obtained from various Streptococcus pneumoniae serotypes","volume":"320","author":"Gaikwad","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.biologicals.2024.101784_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117859","article-title":"Simultaneous purification and depolymerization of Streptococcus pneumoniae serotype 2 capsular polysaccharides by trifluoroacetic acid","volume":"261","author":"Gaikwad","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.biologicals.2024.101784_bib60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/cr960425x","article-title":"Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by Br\u00f8nsted acids and bases","volume":"98","author":"Oivanen","year":"1998","journal-title":"Chem Rev"},{"key":"10.1016\/j.biologicals.2024.101784_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/iai.37.1.89-103.1982","article-title":"Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides","volume":"37","author":"Zon","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2024.101784_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/bip.20087","article-title":"Base hydrolysis of phosphodiester bonds in pneumococcal polysaccharides","volume":"75","author":"Pujar","year":"2004","journal-title":"Biopolymers: Original Research on Biomolecules"},{"key":"10.1016\/j.biologicals.2024.101784_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.mie.2016.05.015","article-title":"Enzymatic cleavage of glycosidic bonds: strategies on how to set up and control a QM\/MM metadynamics simulation","volume":"577","author":"Raich","year":"2016","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biologicals.2024.101784_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00316-18","article-title":"Enzymatic hydrolysis of pneumococcal capsular polysaccharide renders the bacterium vulnerable to host defense","volume":"86","author":"Middleton","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2024.101784_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.72.1858.151","article-title":"The specific action of a bacterial enzyme on pneumococci of type III","volume":"72","author":"Avery","year":"1930","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2024.101784_bib66","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1016\/S0021-9258(18)47558-8","article-title":"Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen","volume":"262","author":"Wessels","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib67","series-title":"Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides","author":"Zon","year":"1982"},{"key":"10.1016\/j.biologicals.2024.101784_bib68","series-title":"Microwave assisted extraction of polysaccharide","author":"Soria","year":"2015"},{"key":"10.1016\/j.biologicals.2024.101784_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1515\/pac-2014-0711","article-title":"Microwave-assisted modifications of polysaccharides","volume":"86","author":"Desbri\u00e8res","year":"2014","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tifs.2020.11.018","article-title":"Ultrasound modified polysaccharides: a review of structure, physicochemical properties, biological activities and food applications","volume":"107","author":"Cui","year":"2021","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.biologicals.2024.101784_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.carres.2015.02.008","article-title":"Potential effect of ultrasound on carbohydrates","volume":"410","author":"Bera","year":"2015","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.biologicals.2024.101784_bib72","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1039\/C8CS00495A","article-title":"Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification","volume":"47","author":"Berti","year":"2018","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.biologicals.2024.101784_bib73","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0264-410X(96)00148-X","article-title":"The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity","volume":"15","author":"Laferriere","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.570185","article-title":"Glycoconjugations of biomolecules by chemical methods","volume":"8","author":"Sarkar","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib75","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/bioengineering9120774","article-title":"Conjugation mechanism for pneumococcal glycoconjugate vaccines: classic and emerging methods","volume":"9","author":"Morais","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.biologicals.2024.101784_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/polym15153316","article-title":"Polyethylene glycol-mediated directional conjugation of biological molecules for enhanced immunoassays at the point-of-care","volume":"15","author":"Battalapalli","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.biologicals.2024.101784_bib77","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2013.03.008","article-title":"PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine","volume":"172","author":"Huang","year":"2013","journal-title":"J Contr Release"},{"key":"10.1016\/j.biologicals.2024.101784_bib78","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2117949","article-title":"Multi-valent pneumococcal conjugate vaccine for global health: from problem to platform to production","volume":"18","author":"Datta","year":"2022","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2024.101784_bib79","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1093\/infdis\/jiz297","article-title":"Eliminating meningococcal epidemics from the African meningitis belt: the case for advanced prevention and control using next-generation meningococcal conjugate vaccines","volume":"220","author":"Alderson","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101453","article-title":"Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design","volume":"298","author":"Duke","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101755","article-title":"Expanding polysaccharide\u2013protein coupling of glycoconjugate vaccines","volume":"298","author":"Berti","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2024.101784_bib82","article-title":"Activation and conjugation of soluble polysaccharides using 1-cyano-4-dimethylaminopyridine tetrafluoroborate (Cdap)","volume":"2021","author":"Lees","year":"2021","journal-title":"JoVE"},{"key":"10.1016\/j.biologicals.2024.101784_bib83","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0264-410X(99)00370-9","article-title":"Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides","volume":"18","author":"Shafer","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib84","first-page":"1","article-title":"Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridine tetrafluoroborate (CDAP) for use in protein\u2013polysaccharide conjugate vaccines and immunological reagents. iii optimization of CDAP activation","volume":"8","author":"Lees","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.biologicals.2024.101784_bib85","volume":"vol. 115","year":"1981"},{"key":"10.1016\/j.biologicals.2024.101784_bib86","series-title":"Novel method for stabilization of bacterial capsular polyoses","author":"Dhere","year":"2021"},{"key":"10.1016\/j.biologicals.2024.101784_bib87","series-title":"Novel method for stabilization of polysaccharide protein constructs","author":"Kapre","year":"2022"},{"key":"10.1016\/j.biologicals.2024.101784_bib88","doi-asserted-by":"crossref","first-page":"13564","DOI":"10.1073\/pnas.1307228110","article-title":"Multiple antigen-presenting system (MAPS) to induce comprehensive B-and T-cell immunity","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2024.101784_bib89","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1016\/j.vaccine.2022.05.079","article-title":"Phase 1\/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years","volume":"40","author":"Chichili","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib90","doi-asserted-by":"crossref","first-page":"34921","DOI":"10.1021\/acsomega.2c03481","article-title":"Addition of lauryldimethylamine N-oxide (LDAO) to a copper-free click chemistry reaction improves the conjugation efficiency of a cell-free generated CRM197 variant to clinically important Streptococcus pneumoniae serotypes","volume":"7","author":"Bautista","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.biologicals.2024.101784_bib91","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2021.03.070","article-title":"Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)","volume":"39","author":"Fairman","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib92","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/eji.1830251202","article-title":"Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects","volume":"25","author":"Raju","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.biologicals.2024.101784_bib93","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib94","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/nar\/12.10.4063","article-title":"The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197","volume":"12","author":"Giannini","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biologicals.2024.101784_bib95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/357216a0","article-title":"The crystal structure of diphtheria toxin","volume":"357","author":"Choe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2024.101784_bib96","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-021-01588-1","article-title":"Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli","volume":"20","author":"Samaras","year":"2021","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.biologicals.2024.101784_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-018-0090-4","article-title":"A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13","volume":"3","author":"Reglinski","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.biologicals.2024.101784_bib98","series-title":"Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof","author":"Dhere","year":"2016"},{"key":"10.1016\/j.biologicals.2024.101784_bib99","series-title":"Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof","author":"Dhere","year":"2021"},{"key":"10.1016\/j.biologicals.2024.101784_bib100","series-title":"Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof","author":"Dhere","year":"2024"},{"key":"10.1016\/j.biologicals.2024.101784_bib101","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1016\/j.vaccine.2008.09.045","article-title":"Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond","volume":"26","author":"Lahiri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib102","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/CVI.00153-07","article-title":"Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome","volume":"14","author":"Morefield","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2024.101784_bib103","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.biologicals.2024.101784_bib104","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/3-540-32636-7_6","article-title":"Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA","author":"McCluskie","year":"2006","journal-title":"From Innate Immunity to Immunological Memory"},{"key":"10.1016\/j.biologicals.2024.101784_bib105","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib106","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.vaccine.2008.06.058","article-title":"Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib107","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1023\/A:1015994006859","article-title":"Aluminum compounds used as adjuvants in vaccines","volume":"7","author":"Shirodkar","year":"1990","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.biologicals.2024.101784_bib108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/PDT-120017526","article-title":"Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins","volume":"8","author":"Iyer","year":"2003","journal-title":"Pharmaceut Dev Technol"},{"key":"10.1016\/j.biologicals.2024.101784_bib109","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3201\/eid2910.230519","article-title":"Serotype distribution and disease severity in adults hospitalized with Streptococcus pneumoniae infection, bristol and bath, UK, 2006\u20122022","volume":"29","author":"Hyams","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib110","author":"Lansbury"},{"key":"10.1016\/j.biologicals.2024.101784_bib111","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/INF.0000000000000279","article-title":"Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children","volume":"33","author":"Loughlin","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.biologicals.2024.101784_bib112","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2024.101784_bib113","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib114","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41598-019-41983-8","article-title":"Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 24F in Denmark","volume":"9","author":"Kavalari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.biologicals.2024.101784_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.18683\/germs.2017.1112","article-title":"Streptococcus pneumoniae serotype prevalence and antibiotic resistance among young children with invasive pneumococcal disease: experience from a tertiary care center in South India","volume":"7","author":"Nagaraj","year":"2017","journal-title":"Germs"},{"key":"10.1016\/j.biologicals.2024.101784_bib116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3201\/eid3001.221927","article-title":"Disease-associated Streptococcus pneumoniae genetic variation","volume":"30","author":"Yang","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib117","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/340400","article-title":"Resistance among Streptococcus pneumoniae: implications for drug selection","volume":"34","author":"Appelbaum","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib118","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(67)92346-X","article-title":"A resistant pneumococcus","volume":"290","author":"Hansman","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2024.101784_bib119","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.biologicals.2024.101784_bib120","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1086\/382696","article-title":"Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?","volume":"38","author":"Nuermberger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9343(99)00107-2","article-title":"New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae","volume":"107","author":"Tomasz","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.biologicals.2024.101784_bib122","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.50.30423","article-title":"Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014","volume":"21","author":"Sheppard","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.biologicals.2024.101784_bib123","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1128\/AAC.03344-14","article-title":"Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States","volume":"58","author":"Richter","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biologicals.2024.101784_bib124","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/jac\/dkv107","article-title":"Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007\u201313","volume":"70","author":"Golden","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.biologicals.2024.101784_bib125","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.vaccine.2016.03.058","article-title":"Invasive Streptococcus pneumoniae in Canada, 2011\u20132014: characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F","volume":"34","author":"Golden","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib126","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.01778-16","article-title":"Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States","volume":"55","author":"Olarte","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib127","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","volume":"34","author":"Nakano","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2024.101784_bib128","first-page":"153","article-title":"Emerging resistant serotypes of invasive Streptococcus pneumoniae","author":"Elshafie","year":"2016","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.biologicals.2024.101784_bib129","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.30708","article-title":"Emergence of neoteric serotypes among multidrug resistant strains of Streptococcus pneumoniae prevalent in Egypt","volume":"9","author":"Bahy","year":"2016","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.biologicals.2024.101784_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-0941-9","article-title":"Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era","volume":"15","author":"Van der Linden","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.biologicals.2024.101784_bib131","article-title":"Recent progress in pneumococcal protein vaccines","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105624000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105624000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:28:30Z","timestamp":1725272910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105624000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":131,"alternative-id":["S1045105624000411"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2024.101784","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2024.101784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101784"}}